Related Experiment Videos
Brain manganese concentrations in human aging and Alzheimer's disease
Abstract:
Manganese levels have been measured in various brain regions in Alzheimer's disease (AD) and aging using instrumental neutron activation analysis. Mn grand mean for all regions was 0.261 micrograms/g for adult controls and 0.245 micrograms/g for AD and the differences were not statistically significant (p less than 0.05). Highest Mn levels were found in the basal ganglia in controls and AD. No significant alterations in Mn were found with advancing age suggesting that the brain has an efficient homeostatic mechanism regulating Mn concentrations. Mn exhibited a significant positive correlation with Fe. Infants had a significantly lower brain Mn level compared to adults.
Insights
Brain manganese (Mn) levels do not significantly differ between Alzheimer's disease patients and controls. Age does not alter brain Mn concentrations, indicating effective homeostatic regulation in adults.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Manganese (Mn) is an essential trace element crucial for brain function.
- Alterations in metal ion concentrations are implicated in neurodegenerative diseases like Alzheimer's disease (AD).
- Understanding Mn homeostasis in the aging brain is vital for neurological health research.
Purpose of the Study:
- To quantify and compare manganese levels in brain regions of Alzheimer's disease patients and age-matched controls.
- To investigate the relationship between manganese concentration and aging in the human brain.
- To explore correlations between manganese and iron levels in brain tissue.
Main Methods:
- Instrumental neutron activation analysis (INAA) was employed to measure Mn concentrations.
- Brain tissue samples from control and Alzheimer's disease subjects were analyzed.
- Statistical analyses were performed to assess differences and correlations.
Main Results:
- No statistically significant differences in grand mean Mn levels were observed between Alzheimer's disease (0.245 µg/g) and control (0.261 µg/g) groups.
- Manganese levels were highest in the basal ganglia for both control and AD groups.
- No significant Mn alterations were found with advancing age, and Mn showed a positive correlation with iron (Fe).
- Infants exhibited significantly lower brain Mn levels compared to adults.
Conclusions:
- Brain manganese concentrations are not significantly altered in Alzheimer's disease.
- The aging brain maintains stable manganese levels, suggesting robust homeostatic mechanisms.
- Manganese homeostasis appears to be effectively regulated throughout the lifespan, with notable differences between infants and adults.